Citigroup provided a buy rating for Claritev stock.
1 report, 1 independent
Updated Aug 18
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Citigroup provided a buy rating for Claritev stock.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Claritev
American technology company supporting healthcare
Nothing else this week.
-
Citigroup
American investment bank and financial services corporation
Related events
- Citigroup maintained a market outperform rating for Ethos Technologies Inc. on November 6, 2026.
- Citigroup and Benchmark issued buy ratings for Strategy shares, while MarketBeat reported the consensus rating for the stock.
- Citigroup reiterated a market outperform rating for Capital Southwest Corporation.
- Jefferies, Citigroup, and Leerink Partners issued rating updates and price targets for Phathom Pharmaceuticals.
- Citigroup upgraded its target price and gave a buy rating for Fortrea.